CAPTAIN STUDY: TREATMENT OUTCOMES FROM FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ACCORDING TO HISTORY OF SEVERE ASTHMA EXACERBATIONS

被引：0
|
作者：
Oppenheimer, J.
Brusselle, G.
Busse, W.
Fowler, A.
Jain, N.
Mannino, D.
Pavord, I.
Win, P.
Zarankaite, A.
Kerwin, E.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P202
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 50 条
  • [31] Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
    Bogart, Michael
    Germain, Guillaume
    Laliberte, Francois
    Mahendran, Malena
    Duh, Mei Sheng
    Dirocco, Kristi
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    Balkissoon, Ronald
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1309 - 1322
  • [32] Triple Therapy of Fluticasone Furoate, Umeclidinium, Vilanterol- A Compelling Choice in Severe Chronic Obstructive Pulmonary Disease
    Nathan, B. Jagan
    Sahay, Melina, I
    Gautham, A. K.
    Sriram, D. K.
    George, Melvin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (02) : CP7 - CP7
  • [33] Within-Trial Cost Analysis of COPD Exacerbations From the Summit Clinical Outcomes Study of Fluticasone Furoate/Vilanterol Inhalation
    Stanford, Richard
    Coutinho, Anna
    Eaddy, Michael
    Yue, Binglin
    Bogart, Michael
    CHEST, 2017, 152 (04) : 183A - 183A
  • [34] Efficacy and safety of vilanterol and fluticasone furoate/vilanterol in the treatment of asthma: a systematic review and meta-analysis
    Zhou, Huimin
    Liu, Chuntao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 8898 - 8911
  • [35] COST - EFFECTIVENESS ANALYSIS OF VILANTEROL/FLUTICASONE FUROATE FOR ASTHMA TREATMENT IN THE RUSSIAN FEDERATION
    Makarova, E.
    Yagudina, R.
    Kulikov, A.
    VALUE IN HEALTH, 2018, 21 : S412 - S412
  • [36] Safety And Efficacy Of Vilanterol And Fluticasone Furoate/vilanterol In The Treatment Of Asthma: A Systematic Review And Meta-Analysis
    Zhou, H.
    Liu, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [37] Captain Study: Treatable Traits and the Outcome of Treatment with Inhaled Fluticasone Furoate/Umeclidinium/Vilanterol ( FF/UMEC/VI) Versus FF/VI Therapies in Patients with Uncontrolled Asthma, A Pre-Specified Subgroup Analysis
    Pavord, I. D.
    Fowler, A.
    Kerstjens, H.
    Papi, A.
    Hartley, B.
    Goldfrad, C.
    Barnes, N.
    Oppenheimer, J.
    Pizzichini, E.
    Lee, L. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [38] Resource Use, Costs and Clinical Outcomes Among COPD Patients Initiated on Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History
    Sethi, S.
    Clark, B.
    Bengtson, L.
    Buysman, E.
    Palli, S.
    Sargent, A.
    Shaikh, A.
    Ferguson, G. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [39] COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA
    Hanania, Nicola A.
    Bunner, Scott H.
    Bengtson, Lindsay G. S.
    Ismaila, Afisi S.
    Bogart, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 407 - 418
  • [40] Effectiveness of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol on asthma control in the Salford Lung Study
    Jacques, Loretta
    Bakerly, Nawar Diar
    New, John P.
    Svedsater, Henrik
    Lay-Flurrie, James
    Leather, David A.
    JOURNAL OF ASTHMA, 2019, 56 (07) : 748 - 757
12345